Thyrotoxicosis
📧 Sign up to get email alerts when something new happens for Thyrotoxicosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-12Clinical Trial Update: Evaluating an AI Tool for Detecting Thyrotoxic States
An ongoing clinical trial sponsored by THYROSCOPE INC. is evaluating an AI tool to detect thyrotoxic states in Graves' disease and hyperthyr…
-
CLINICAL_TRIALS research · 2025-06-08Clinical Trial Update: Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism [NA]
A clinical trial evaluating whether a zinc, selenium, and L-tyrosine supplement can prevent thyrotoxicosis in people with the SEPP1 polymorp…
-
EMA approval · 2025-03-11EMA Authorised: Emcitate (tiratricol) — Rare Thyroid Therapeutics International AB
The EMA authorised Emcitate (tiratricol) for treating thyrotoxicosis and certain hereditary neurodegenerative disorders of the nervous syste…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Subacute Thyroiditis in the SARS-CoV-2 Era
A completed clinical trial update examining subacute thyroiditis in the context of SARS-CoV-2 infection. The report highlights thyrotoxicosi…
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: LIthium as Bridging thErapy Prior to Radioactiveiodine in hyperThYroidism [Phase 4]
A Phase 4 clinical trial evaluated lithium as a bridging therapy prior to radioactive iodine in hyperthyroidism; the study is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-01-06FDA Approved: PROPRANOLOL HYDROCHLORIDE — Original Application (Lannett Company, Inc.)
FDA approved the original application for propranolol hydrochloride from Lannett Company, Inc., enabling a generic version to be marketed.
-
FDA approval · 2018-09-19FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Endo USA, Inc.)
FDA approves a supplemental application for Propylthiouracil from Endo USA, Inc.
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
A clinical trial evaluating pulse rate–monitoring activity trackers in thyrotoxicosis has completed, including participants with Graves' dis…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Thiamine Supplement in Patients With Severe Hyperthyroidism [NA]
This update notes the completion of a clinical trial evaluating thiamine supplementation in patients with severe thyrotoxicosis.
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Thyrotropin Over-suppression and Heart
The clinical trial NCT02645786 has completed. It examines thyrotropin over-suppression and its impact on thyroid cancer and related heart co…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Differential Diagnosis of STA-PSV in Thyrotoxicosis
Clinical trial update about using peak systolic velocity of the superior thyroid artery to differentiate causes of thyrotoxicosis, including…
-
FDA approval · 2012-01-27FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Ipca Laboratories Limited)
FDA approved a supplemental application for propranolol hydrochloride from Ipca Laboratories Limited, finalizing a regulatory update for the…
-
FDA approval · 2011-08-22FDA Approved: PROPYLTHIOURACIL — Supplemental Application (QUAGEN PHARMACEUTICALS LLC)
The FDA approved a supplemental ANDA for propylthiouracil from Quagen Pharmaceuticals LLC, authorizing the marketing of an additional generi…
-
FDA approval · 2010-12-15FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Propylthiouracil from Actavis Pharma, Inc., for the generic drug Propylthiouracil.